For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious ...
New research from CSIRO, Australia's national science agency, has unveiled the power of personalized goal-setting for ...
New FDA draft guidance for drugmakers focuses on trial design for developing obesity treatments. Read more here.
This low-calorie, low-carb commercial diet plan offers fast weight loss overseen by a health care professional.
The Corporate Transparency Act mandates new reporting requirements for small businesses that will impact 32 million ...
As the New Year begins, the U.K.’s Medicines and Healthcare Products Regulatory Agency (MHRA) is urging the public to avoid ...